Back to Agenda
Exploring Responder-Patient Clinical Study Design Approaches
Session Chair(s)
Joan Meyer
, Covance, United States
Finding patients with a better chance of responding to a drug continues to evolve. This session will discuss how clinical trial design approaches can be employed, as well as how stakeholders can collaborate to accelerate advancements.
Learning Objective : Discuss the concept of a responder in a clinical trial; Describe ways to use data to increase the recruitment of responders into clinical studies.
Speaker(s)
Joan Meyer
, Covance, United States
Industry Perspective
Christopher Leptak, MD, PHD
Executive Vice President, Drug and Biological Products, Greenleaf Health, Inc., United States
FDA Perspective on Use of Biomarkers to Identify Treatment Responders
Cecile Holweg
, Genentech, A Member of the Roche Group, United States
Pharmaceutical Perspective
Have an account?